Overview

Topical Roflumilast in Adults With Atopic Dermatitis

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of topical roflumilast on the reduction of atopic dermatitis lesions in adults with atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Takeda
Treatments:
Phosphodiesterase 4 Inhibitors